Nifty

:

14650.45

Sensex

:

49829.68

129.30 (0.89%)
431.39 (0.87%)

Login

Nifty
Sensex

:
:

14650.45
49829.68

129.30 (0.89%)
431.39 (0.87%)

Neuland Laboratories Ltd.

Pharmaceuticals & Drugs - API

Rating :

65/99

BSE: 524558 | NSE: NEULANDLAB

Watchlist

NSE BSE

1384.20

19-Jan-2021

Open
High
Low
Previous Close

1409.85
1463.55
1362.55
1376.60

Volume
Traded Value (lacs)
52 Week High
52 Week Low

356210
5063.50
1463.55
245.75

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,772.45
46.23
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,988.52
0.14%
2.38

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

6.75
8.38
13.08

EBITDA CAGR (%)

10 Years
5 Years
3 Years

7.99
4.84
15.10

PAT CAGR (%)

10 Years
5 Years
3 Years

11.85
-9.92
10.36

P:E (Median)

8 Years
5 Years
3 Years

31.41
36.58
41.39

P:BV (Average)

8 Years
5 Years
3 Years

2.76
3.03
1.85

EV:EBITDA (Average)

8 Years
5 Years
3 Years

11.26
13.63
14.09

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 241.39 186.22 29.63% 205.42 181.01 13.49% 191.87 172.66 11.13% 203.62 171.47 18.75%
Expenses 200.63 161.38 24.32% 171.69 162.44 5.69% 161.87 154.26 4.93% 175.56 155.63 12.81%
EBITDA 40.76 24.83 64.16% 33.74 18.57 81.69% 29.99 18.40 62.99% 28.06 15.84 77.15%
EBIDTM 16.89% 13.34% 16.42% 10.26% 15.63% -0.29% 13.78% 9.24%
Other Income 0.61 0.57 7.02% 0.70 0.52 34.62% 1.78 1.33 33.83% 1.02 0.41 148.78%
Interest 3.51 4.78 -26.57% 5.37 4.03 33.25% 7.07 4.71 50.11% 5.69 3.00 89.67%
Depreciation 9.27 8.28 11.96% 8.86 7.55 17.35% 7.63 6.93 10.10% 7.82 7.35 6.39%
PBT 28.59 12.34 131.69% 20.20 7.50 169.33% 17.08 8.09 111.12% 15.58 5.90 164.07%
Tax 7.25 3.76 92.82% 5.15 1.89 172.49% 26.43 1.36 1,843.38% 4.53 1.30 248.46%
PAT 21.34 8.57 149.01% 15.06 5.61 168.45% -9.35 6.73 - 11.04 4.60 140.00%
PATM 8.84% 4.60% 7.33% 3.10% -4.87% 2.87% 5.42% 2.68%
EPS 16.67 6.70 148.81% 11.76 4.39 167.88% -7.31 5.26 - 8.63 3.59 140.39%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 241.39 186.22 29.63% 205.42 181.01 13.49% 191.64 172.66 10.99% 203.84 171.48 18.87%
Expenses 200.53 161.27 24.34% 171.58 162.34 5.69% 161.53 154.18 4.77% 175.68 155.52 12.96%
EBITDA 40.86 24.95 63.77% 33.84 18.66 81.35% 30.12 18.49 62.90% 28.16 15.96 76.44%
EBIDTM 16.93% 13.40% 16.47% 10.31% 14.01% 14.01% 13.81% 9.31%
Other Income 0.61 0.57 7.02% 0.70 0.52 34.62% 1.78 1.33 33.83% 1.02 0.41 148.78%
Interest 3.51 4.78 -26.57% 5.37 4.03 33.25% 7.07 4.71 50.11% 5.69 3.00 89.67%
Depreciation 9.27 8.28 11.96% 8.86 7.55 17.35% 7.63 6.93 10.10% 7.82 7.35 6.39%
PBT 28.69 12.46 130.26% 20.31 7.60 167.24% 17.20 8.18 110.27% 15.67 6.01 160.73%
Tax 7.25 3.77 92.31% 5.15 1.89 172.49% 26.49 1.54 1,620.13% 4.56 1.32 245.45%
PAT 21.44 8.69 146.72% 15.16 5.71 165.50% -9.30 6.64 - 11.11 4.69 136.89%
PATM 8.88% 4.67% 7.38% 3.15% 7.11% 7.11% 5.45% 2.74%
EPS 16.62 6.74 146.59% 11.75 4.42 165.84% 28.29 28.29 0.00% 8.61 3.64 136.54%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 842.30 762.71 666.83 527.41 578.89 509.97 469.15 465.69 460.59 448.23 396.80 Net Sales Growth 18.41% 14.38% 26.43% -8.89% 13.51% 8.70% 0.74% 1.11% 2.76% 12.96% Cost Of Goods Sold 407.10 380.20 366.24 238.37 262.90 253.46 243.99 246.53 269.20 284.69 249.90 Gross Profit 435.20 382.51 300.59 289.04 315.99 256.52 225.16 219.16 191.39 163.54 146.90 GP Margin 51.67% 50.15% 45.08% 54.80% 54.59% 50.30% 47.99% 47.06% 41.55% 36.49% 37.02% Total Expenditure 709.75 661.25 608.96 477.38 473.20 430.10 402.79 395.39 403.14 402.05 349.71 Power & Fuel Cost - 32.75 26.81 25.95 25.78 22.24 22.53 18.31 18.97 15.84 13.62 % Of Sales - 4.29% 4.02% 4.92% 4.45% 4.36% 4.80% 3.93% 4.12% 3.53% 3.43% Employee Cost - 118.48 104.47 95.73 84.92 59.89 49.16 36.26 34.88 30.78 26.06 % Of Sales - 15.53% 15.67% 18.15% 14.67% 11.74% 10.48% 7.79% 7.57% 6.87% 6.57% Manufacturing Exp. - 64.84 50.10 55.54 44.90 39.31 43.56 40.98 35.86 33.76 29.98 % Of Sales - 8.50% 7.51% 10.53% 7.76% 7.71% 9.28% 8.80% 7.79% 7.53% 7.56% General & Admin Exp. - 25.18 24.56 30.38 25.23 26.90 20.77 14.50 14.43 12.27 12.76 % Of Sales - 3.30% 3.68% 5.76% 4.36% 5.27% 4.43% 3.11% 3.13% 2.74% 3.22% Selling & Distn. Exp. - 26.59 28.01 26.50 23.14 26.41 20.31 33.64 21.35 18.89 16.06 % Of Sales - 3.49% 4.20% 5.02% 4.00% 5.18% 4.33% 7.22% 4.64% 4.21% 4.05% Miscellaneous Exp. - 13.21 8.76 4.91 6.34 1.89 2.47 5.17 8.45 5.80 16.06 % Of Sales - 1.73% 1.31% 0.93% 1.10% 0.37% 0.53% 1.11% 1.83% 1.29% 0.33% EBITDA 132.55 101.46 57.87 50.03 105.69 79.87 66.36 70.30 57.45 46.18 47.09 EBITDA Margin 15.74% 13.30% 8.68% 9.49% 18.26% 15.66% 14.14% 15.10% 12.47% 10.30% 11.87% Other Income 4.11 3.89 3.49 4.53 1.17 1.62 0.78 3.41 4.00 2.16 2.86 Interest 21.64 21.57 15.66 18.92 21.08 24.47 27.35 24.55 31.33 33.27 29.84 Depreciation 33.58 31.28 25.86 22.10 19.23 15.74 15.32 14.94 14.62 14.89 15.41 PBT 81.45 52.50 19.84 13.54 66.55 41.28 24.48 34.22 15.50 0.18 4.70 Tax 43.36 36.62 3.69 1.73 20.17 14.87 8.70 7.56 1.86 -1.85 -0.37 Tax Rate 53.24% 69.75% 18.60% 12.78% 30.31% 36.02% 35.54% 22.09% 12.00% -1027.78% -7.87% PAT 38.09 15.88 16.14 11.81 46.38 26.41 15.78 26.67 13.64 2.03 5.07 PAT before Minority Interest 38.09 15.88 16.14 11.81 46.38 26.41 15.78 26.67 13.64 2.03 5.07 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.52% 2.08% 2.42% 2.24% 8.01% 5.18% 3.36% 5.73% 2.96% 0.45% 1.28% PAT Growth 49.31% -1.61% 36.66% -74.54% 75.62% 67.36% -40.83% 95.53% 571.92% -59.96% EPS 29.76 12.41 12.61 9.23 36.23 20.63 12.33 20.84 10.66 1.59 3.96

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 842.29 762.71 666.83 527.41 578.89 509.97 469.15 465.69 460.59 448.50 396.91 Net Sales Growth 18.40% 14.38% 26.43% -8.89% 13.51% 8.70% 0.74% 1.11% 2.70% 13.00% Cost Of Goods Sold 4,965.12 380.20 366.24 238.37 262.90 253.46 243.99 246.53 269.20 284.69 249.90 Gross Profit -4,122.83 382.51 300.59 289.04 315.99 256.52 225.16 219.16 191.39 163.81 147.01 GP Margin -489.48% 50.15% 45.08% 54.80% 54.59% 50.30% 47.99% 47.06% 41.55% 36.52% 37.04% Total Expenditure 709.32 660.82 608.46 476.98 472.55 429.52 402.53 395.08 402.91 401.69 349.65 Power & Fuel Cost - 32.75 26.81 25.95 25.78 22.24 22.53 18.31 18.97 15.84 13.62 % Of Sales - 4.29% 4.02% 4.92% 4.45% 4.36% 4.80% 3.93% 4.12% 3.53% 3.43% Employee Cost - 123.56 110.46 102.99 92.74 65.38 51.81 41.74 40.75 35.92 29.73 % Of Sales - 16.20% 16.56% 19.53% 16.02% 12.82% 11.04% 8.96% 8.85% 8.01% 7.49% Manufacturing Exp. - 64.84 50.10 55.54 44.90 39.31 43.56 40.98 35.86 33.76 29.98 % Of Sales - 8.50% 7.51% 10.53% 7.76% 7.71% 9.28% 8.80% 7.79% 7.53% 7.55% General & Admin Exp. - 27.75 27.49 33.32 28.30 29.72 23.59 15.95 16.27 14.27 14.29 % Of Sales - 3.64% 4.12% 6.32% 4.89% 5.83% 5.03% 3.43% 3.53% 3.18% 3.60% Selling & Distn. Exp. - 18.30 18.28 14.04 11.16 17.52 14.54 26.57 13.51 11.42 10.80 % Of Sales - 2.40% 2.74% 2.66% 1.93% 3.44% 3.10% 5.71% 2.93% 2.55% 2.72% Miscellaneous Exp. - 13.42 9.08 6.77 6.78 1.89 2.52 4.99 8.35 5.79 10.80 % Of Sales - 1.76% 1.36% 1.28% 1.17% 0.37% 0.54% 1.07% 1.81% 1.29% 0.33% EBITDA 132.98 101.89 58.37 50.43 106.34 80.45 66.62 70.61 57.68 46.81 47.26 EBITDA Margin 15.79% 13.36% 8.75% 9.56% 18.37% 15.78% 14.20% 15.16% 12.52% 10.44% 11.91% Other Income 4.11 3.89 3.49 4.53 1.17 1.78 0.78 3.44 4.06 2.19 2.90 Interest 21.64 21.57 15.66 18.93 21.09 24.48 27.36 24.56 31.33 33.27 29.84 Depreciation 33.58 31.28 25.86 22.10 19.23 15.74 15.32 14.94 14.62 14.89 15.41 PBT 81.87 52.92 20.34 13.93 67.19 42.00 24.72 34.55 15.78 0.83 4.92 Tax 43.45 36.71 3.90 1.87 20.32 14.92 8.79 7.80 1.96 -1.74 -0.35 Tax Rate 53.07% 69.37% 19.17% 13.42% 30.24% 35.52% 35.56% 22.58% 12.42% -209.64% -7.11% PAT 38.41 16.21 16.44 12.06 46.86 27.33 15.94 26.80 13.86 2.56 5.29 PAT before Minority Interest 38.41 16.21 16.44 12.06 46.86 27.08 15.93 26.75 13.82 2.57 5.27 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.25 0.01 0.05 0.04 -0.01 0.02 PAT Margin 4.56% 2.13% 2.47% 2.29% 8.09% 5.36% 3.40% 5.75% 3.01% 0.57% 1.33% PAT Growth 49.28% -1.40% 36.32% -74.26% 71.46% 71.46% -40.52% 93.36% 441.41% -51.61% EPS 30.01 12.66 12.84 9.42 36.61 21.35 12.45 20.94 10.83 2.00 4.13

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 705.55 695.58 554.78 542.78 184.17 159.83 122.60 98.58 75.10 73.13 Share Capital 12.90 12.90 8.95 8.95 8.95 8.95 7.73 7.72 5.47 5.47 Total Reserves 692.64 682.68 234.98 222.97 175.22 150.87 114.87 90.87 69.61 67.66 Non-Current Liabilities 162.21 103.13 145.78 53.83 69.01 54.58 52.20 61.85 58.90 74.25 Secured Loans 77.37 60.72 103.49 29.81 33.40 21.22 8.87 26.11 55.90 71.58 Unsecured Loans 0.00 0.00 0.00 0.00 12.00 12.00 25.00 25.00 0.00 0.00 Long Term Provisions 12.18 11.74 9.87 9.28 6.85 6.38 5.14 4.71 3.85 2.67 Current Liabilities 361.99 331.19 370.38 288.24 270.16 296.76 308.46 264.23 289.58 279.97 Trade Payables 120.00 124.00 129.01 88.64 86.17 111.76 93.37 81.49 110.67 104.35 Other Current Liabilities 71.55 57.33 40.57 47.11 54.90 33.16 66.15 42.62 41.44 38.07 Short Term Borrowings 168.17 149.06 199.20 151.08 123.63 145.80 139.62 132.47 132.03 133.97 Short Term Provisions 2.27 0.80 1.59 1.41 5.47 6.04 9.33 7.65 5.43 3.59 Total Liabilities 1,229.75 1,129.90 1,070.94 884.85 523.34 511.17 483.26 424.66 423.58 427.35 Net Block 622.75 511.67 445.01 435.74 138.77 123.07 130.85 135.52 151.29 158.30 Gross Block 714.31 575.42 483.45 454.74 291.78 263.65 258.54 250.39 254.07 246.22 Accumulated Depreciation 91.56 63.75 38.44 19.00 153.00 140.58 127.69 114.87 102.78 87.92 Non Current Assets 715.91 676.96 624.22 510.60 210.00 196.04 196.38 198.10 202.38 209.26 Capital Work in Progress 23.75 104.47 126.09 19.60 40.48 41.47 34.56 35.69 27.15 27.26 Non Current Investment 30.33 30.37 30.37 30.36 7.55 7.67 7.64 7.64 7.67 7.67 Long Term Loans & Adv. 35.78 30.45 22.52 24.69 22.71 23.83 23.32 11.16 5.68 5.09 Other Non Current Assets 3.30 0.00 0.22 0.22 0.50 0.00 0.00 8.09 10.59 10.95 Current Assets 513.83 452.93 446.73 374.24 313.34 315.13 286.89 226.56 221.20 218.08 Current Investments 7.50 7.50 7.50 7.50 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 219.55 192.65 175.09 135.11 126.66 113.40 93.42 92.17 92.42 79.92 Sundry Debtors 189.89 164.02 193.92 181.11 119.11 128.85 118.59 98.50 96.41 99.57 Cash & Bank 45.69 37.35 17.05 12.04 9.04 6.49 6.68 0.28 1.78 4.45 Other Current Assets 51.21 19.64 16.24 13.44 58.53 66.39 68.19 35.61 30.59 34.14 Short Term Loans & Adv. 33.79 31.77 36.93 25.03 46.54 45.17 42.73 25.80 18.91 21.21 Net Current Assets 151.84 121.74 76.35 86.00 43.18 18.37 -21.58 -37.67 -68.38 -61.89 Total Assets 1,229.74 1,129.89 1,070.95 884.84 523.34 511.17 483.27 424.66 423.58 427.34

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 709.96 699.31 558.04 545.62 186.63 161.38 123.99 99.83 76.12 73.62 Share Capital 12.90 12.90 8.95 8.95 8.95 8.95 7.73 7.72 5.47 5.47 Total Reserves 697.06 686.41 238.24 225.81 177.68 152.42 116.26 92.12 70.63 68.15 Non-Current Liabilities 163.39 104.06 146.43 54.37 69.42 54.76 52.33 61.85 58.90 74.25 Secured Loans 77.37 60.72 103.49 29.81 33.40 21.22 8.87 26.11 55.90 71.58 Unsecured Loans 0.00 0.00 0.00 0.00 12.00 12.00 25.00 25.00 0.00 0.00 Long Term Provisions 12.49 11.91 9.87 9.28 6.85 6.38 5.14 4.71 3.85 2.67 Current Liabilities 357.63 326.98 366.93 285.60 268.00 295.14 306.90 262.99 288.53 279.71 Trade Payables 115.56 119.68 124.29 85.92 83.86 111.81 93.94 82.02 110.85 104.49 Other Current Liabilities 71.63 57.45 41.83 47.18 55.02 31.28 63.74 40.46 40.10 37.66 Short Term Borrowings 168.17 149.06 199.20 151.08 123.63 145.80 139.62 132.68 132.03 133.97 Short Term Provisions 2.27 0.80 1.59 1.41 5.50 6.25 9.61 7.83 5.54 3.60 Total Liabilities 1,230.98 1,130.35 1,071.40 885.59 524.05 511.53 483.48 424.98 423.91 427.93 Net Block 622.76 511.69 445.01 435.74 138.77 123.07 130.85 135.52 151.29 158.30 Gross Block 714.33 575.44 483.45 454.74 291.78 263.65 258.54 250.39 254.07 246.22 Accumulated Depreciation 91.57 63.75 38.44 19.00 153.00 140.58 127.69 114.87 102.78 87.92 Non Current Assets 715.79 676.88 624.20 510.54 209.87 195.76 195.93 197.66 201.92 208.83 Capital Work in Progress 23.75 104.47 126.09 19.60 40.48 41.47 34.56 35.69 27.15 27.26 Non Current Investment 30.17 30.21 30.21 30.20 7.39 7.39 7.36 7.36 7.39 7.39 Long Term Loans & Adv. 35.81 30.51 22.66 24.79 22.73 23.83 23.15 10.99 5.50 4.94 Other Non Current Assets 3.30 0.00 0.22 0.22 0.50 0.00 0.00 8.09 10.59 10.95 Current Assets 515.19 453.47 447.19 375.04 314.19 315.77 287.55 227.32 221.98 219.10 Current Investments 7.50 7.50 7.50 7.50 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 219.55 192.65 175.09 135.11 126.66 113.40 93.42 92.17 92.42 79.92 Sundry Debtors 189.89 164.02 193.92 181.11 119.11 128.85 118.59 98.50 96.41 99.70 Cash & Bank 46.98 37.84 17.26 12.49 9.71 6.98 7.07 1.18 2.70 5.23 Other Current Assets 51.27 19.69 16.28 13.53 58.70 66.53 68.47 35.48 30.45 34.25 Short Term Loans & Adv. 33.80 31.77 37.15 25.30 46.68 45.23 43.01 25.66 18.75 21.29 Net Current Assets 157.55 126.49 80.27 89.45 46.18 20.63 -19.35 -35.66 -66.54 -60.62 Total Assets 1,230.98 1,130.35 1,071.39 885.58 524.06 511.53 483.48 424.98 423.90 427.93

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 56.63 69.60 11.52 38.89 44.65 13.07 48.53 26.16 49.22 32.18 PBT 52.50 19.84 13.54 66.55 41.28 24.48 34.22 15.50 0.18 4.70 Adjustment 58.14 38.93 40.35 43.95 33.85 36.35 34.39 42.26 44.29 41.76 Changes in Working Capital -49.30 15.92 -39.20 -55.25 -18.76 -38.74 -16.75 -30.81 5.23 -13.87 Cash after chg. in Working capital 61.33 74.68 14.69 55.25 56.38 22.08 51.86 26.95 49.70 32.58 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -4.70 -5.09 -3.17 -16.36 -11.73 -9.01 -3.33 -0.79 -0.48 -0.40 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -48.68 -77.22 -116.29 -42.11 -19.86 -14.13 -9.78 -7.22 -5.21 -8.07 Net Fixed Assets -58.17 -70.35 -135.20 -142.08 -27.14 -12.02 -7.02 -4.86 -7.74 -7.76 Net Investments 0.04 0.00 -0.01 -30.31 0.12 -0.03 0.00 0.03 0.00 0.00 Others 9.45 -6.87 18.92 130.28 7.16 -2.08 -2.76 -2.39 2.53 -0.31 Cash from Financing Activity -5.48 11.98 104.86 -0.08 -23.62 1.15 -38.74 -20.16 -43.70 -24.25 Net Cash Inflow / Outflow 2.47 4.36 0.09 -3.30 1.18 0.08 0.00 -1.22 0.31 -0.14 Opening Cash & Equivalents 7.44 3.08 3.00 6.29 0.32 0.23 0.23 1.45 1.13 1.28 Closing Cash & Equivalent 9.92 7.44 3.08 3.00 1.49 0.32 0.23 0.23 1.45 1.13

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 57.34 69.91 11.27 38.68 44.83 13.17 48.77 25.83 49.34 32.33 PBT 52.92 20.34 13.93 67.19 42.00 24.72 34.55 15.78 0.83 4.92 Adjustment 58.28 39.11 40.43 43.96 33.73 36.34 34.37 42.22 44.30 41.78 Changes in Working Capital -49.17 15.47 -40.02 -55.94 -19.17 -38.76 -16.82 -31.35 4.72 -13.98 Cash after chg. in Working capital 62.03 74.91 14.35 55.20 56.56 22.30 52.11 26.65 49.85 32.72 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -4.68 -5.01 -3.08 -16.52 -11.73 -9.13 -3.34 -0.82 -0.51 -0.38 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -48.68 -77.23 -116.29 -42.11 -19.86 -14.13 -9.84 -7.22 -5.21 -8.07 Net Fixed Assets -58.17 -70.35 -135.20 -142.08 -27.14 -12.02 -7.02 -4.86 -7.74 -7.76 Net Investments 0.04 0.00 -0.01 -30.31 0.12 -0.03 0.00 0.03 0.00 0.00 Others 9.45 -6.88 18.92 130.28 7.16 -2.08 -2.82 -2.39 2.53 -0.31 Cash from Financing Activity -5.48 11.98 104.85 -0.09 -23.62 1.15 -38.96 -19.90 -43.70 -24.27 Net Cash Inflow / Outflow 3.18 4.66 -0.17 -3.51 1.35 0.19 -0.03 -1.28 0.42 -0.02 Opening Cash & Equivalents 7.94 3.29 3.44 6.97 0.81 0.62 0.65 1.93 1.51 1.53 Closing Cash & Equivalent 11.20 7.94 3.29 3.44 2.16 0.81 0.62 0.65 1.93 1.51

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 549.21 541.45 273.54 260.03 206.30 178.97 151.75 121.84 130.84 109.99 ROA 1.35% 1.47% 1.21% 6.59% 5.11% 3.17% 5.87% 3.22% 0.48% 1.23% ROE 2.27% 3.44% 4.98% 22.39% 15.44% 11.25% 24.35% 15.92% 2.79% 7.31% ROCE 7.84% 3.95% 4.04% 15.94% 18.46% 15.74% 18.97% 15.55% 11.16% 11.40% Fixed Asset Turnover 1.18 1.26 1.13 1.57 1.86 1.82 1.87 1.86 1.82 1.67 Receivable days 84.68 97.96 129.34 93.22 87.45 94.81 83.45 75.67 78.77 78.31 Inventory Days 98.63 100.64 106.98 81.29 84.66 79.24 71.34 71.66 69.27 68.97 Payable days 67.56 78.05 84.05 68.43 85.33 91.74 81.35 87.51 96.88 90.57 Cash Conversion Cycle 115.76 120.56 152.27 106.08 86.78 82.31 73.45 59.82 51.16 56.71 Total Debt/Equity 0.37 0.33 1.31 0.83 0.99 1.18 1.56 2.16 2.98 3.25 Interest Cover 3.43 2.27 1.72 4.16 2.69 1.90 2.39 1.49 1.01 1.16

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 552.65 544.35 277.21 263.23 209.07 180.72 153.48 123.40 132.65 110.74 ROA 1.37% 1.49% 1.23% 6.65% 5.23% 3.20% 5.89% 3.26% 0.60% 1.28% ROE 2.30% 3.48% 5.02% 22.34% 15.64% 11.24% 24.14% 15.92% 3.49% 7.56% ROCE 7.85% 3.99% 4.07% 15.98% 18.57% 15.75% 18.99% 15.58% 11.35% 11.46% Fixed Asset Turnover 1.18 1.26 1.13 1.57 1.86 1.82 1.87 1.86 1.82 1.67 Receivable days 84.68 97.96 129.34 93.22 87.45 94.81 83.45 75.67 78.78 78.35 Inventory Days 98.63 100.64 106.98 81.29 84.66 79.24 71.34 71.66 69.23 68.95 Payable days 65.43 75.72 82.06 67.03 85.01 92.70 82.14 88.22 97.55 91.06 Cash Conversion Cycle 117.88 122.89 154.27 107.48 87.10 81.35 72.66 59.11 50.45 56.25 Total Debt/Equity 0.37 0.33 1.30 0.82 0.98 1.17 1.55 2.13 2.93 3.23 Interest Cover 3.45 2.30 1.74 4.19 2.72 1.90 2.41 1.50 1.02 1.16

Top Investors:

malabar india fund limited

malabar value fund

icici prudential pharma healthcare and diaganostics (p.h.d) fund

rohinton soli screwvala

mukul mahavir agrawal

kedia securities private limited

siddharth sunder iyer

ashish kacholia

Annual Reports:

News Update:

Neuland Laboratories - Quarterly Results
3rd Nov 2020, 14:14 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback